technology. On Protalix's behalf, being acquired by Pfizer is a great opportunity to cross the chasm with its innovative technology and widely implement it in the pharmaceutical market, in addition to gaining the complementary assets needed for its success. D. Standalone, Synergy and Premium Valuations *Transaction multiples include premiums Stand-alone value Value with synergy Walk-away Price $578,573 $672,772 $528,209 $725,772 $924,841 $580,704 Trading Revenue Multiple Market Cap…
Words 10040 - Pages 41